The estimated Net Worth of Donald Olds is at least $884 dollars as of 31 August 2023. Mr. Olds owns over 381 units of Acasti Pharma Inc stock worth over $884 and over the last 3 years he sold ACST stock worth over $0. In addition, he makes $0 as Independent Director at Acasti Pharma Inc.
Sign up
Mr. Olds ACST stock SEC Form 4 insiders trading
Donald has made over 1 trades of the Acasti Pharma Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he bought 381 units of ACST stock worth $781 on 31 August 2023.
The largest trade he's ever made was buying 381 units of Acasti Pharma Inc stock on 31 August 2023 worth over $781. On average, Donald trades about 95 units every 0 days since 2021. As of 31 August 2023 he still owns at least 381 units of Acasti Pharma Inc stock.
You can see the complete history of Mr. Olds stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Donald Olds biography
Donald Olds is Independent Director of the Company. Mr. Olds is President and Chief Executive Officer of the NEOMED Institute, an R&D organization dedicated to advancing Canadian research discoveries to commercial success. Prior to NEOMED, he was the Chief Operating Officer of Telesta Therapeutics Inc., a TSX-listed biotechnology company, where he was responsible for finance and investor relations, manufacturing operations, business development, human resources and strategy. In 2016, he led the successful sale of Telesta to a larger public biotechnology company. Prior to Telesta, he was President and Chief Executive Officer of Presagia Corp., and Chief Financial Officer and Chief Operating Officer of Aegera Therapeutics, where he was responsible for clinical operations, business development, finance, and mergers and acquisitions. At both Telesta and Aegera, Mr. Olds was responsible for raising more than $100 million in equity financing and leading regional and global licensing transactions with life sciences companies. Mr. Olds is currently Director of Goodfood Market Corp, Chairman of Oxfam Quebec and Director of Presagia Corp. He has extensive past corporate governance experience serving on the boards of private and public for-profit and not-for-profit organizations. He holds an MBA (Finance & Strategy) and M.Sc. (Renewable Resources) from McGill University.
How old is Donald Olds?
Donald Olds is 59, he's been the Independent Director of Acasti Pharma Inc since 2018. There are 5 older and 2 younger executives at Acasti Pharma Inc. The oldest executive at Acasti Pharma Inc is Janelle D'Alvise, 66, who is the Pres, CEO, Corp. Sec. & Director.
What's Donald Olds's mailing address?
Donald's mailing address filed with the SEC is C/O ACASTI PHARMA INC., 2572 BOUL. DANIEL-JOHNSON, 2ND FLOOR, LAVAL, A8, H7T 2R3.
Insiders trading at Acasti Pharma Inc
Over the last 3 years, insiders at Acasti Pharma Inc have traded over $0 worth of Acasti Pharma Inc stock and bought 676,752 units worth $1,252,067 . The most active insiders traders include Vimal Kavuru, John Canan e R. Loch Macdonald. On average, Acasti Pharma Inc executives and independent directors trade stock every 13 days with the average trade being worth of $785,032. The most recent stock trade was executed by Vimal Kavuru on 25 September 2023, trading 676,371 units of ACST stock currently worth $1,251,286.
What does Acasti Pharma Inc do?
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
What does Acasti Pharma Inc's logo look like?
Complete history of Mr. Olds stock trades at Acasti Pharma Inc
Acasti Pharma Inc executives and stock owners
Acasti Pharma Inc executives and other stock owners filed with the SEC include:
-
Janelle D' Alvise,
Pres, CEO, Corp. Sec. & Director -
Janelle D'Alvise,
Pres, CEO, Corp. Sec. & Director -
Brian D. Ford CPA, CA,
Chief Financial Officer -
Dr. Pierre Lemieux,
Co-Founder, COO & Chief Scientific Officer -
Dr. Pierre Lemieux M.D., Ph.D.,
Co-Founder, COO & Chief Scientific Officer -
Pierre Lemieux,
Chief Operating Officer -
Donald Olds,
Independent Director -
Jean-Marie Canan,
Director -
Jean-Daniel Belanger,
Secretary, Director- Corporate Affairs -
Brian Groch,
Chief Commercial Officer -
Laurent Harvey,
Vice President- Clinical and Non-Clinical Affairs -
Brian Ford,
Chief Financial Officer -
Janelle D'Alvise,
President, Chief Executive Officer, Director -
Roderick Carter,
Executive Chairman of the Board -
Prashant Kohli,
VP of Commercial Operations -
Dr. George Kottayil,
Chief Operating Officer of US -
Dr. Yves Lachance Ph.D.,
VP of Quality & Compliance -
Amresh Kumar,
VP Clinical Operations -
R. Loch Macdonald,
Chief Medical Officer -
Robert J Del Aversano,
Principal Financial Officer -
Michael Derby,
Director -
William A Haseltine,
Director -
John Canan,
Director -
Prashant Kohli,
Chief Executive Officer -
Vimal Kavuru,
-
A Brian Davis,
-
George Kottayil,
-
Edward Neugeboren,